In conclusion, our present study demonstrated for the first time that the GPR4/STAT3/VEGFA signaling pathway contributed to the impaired angiogenic capacity of EPCs and that elevating GPR4 could restore the angiogenic capacity of EPCs from CAD patients. This evidence concerns the gene GPR4 and coronary artery disorder.